Description
BSE notifies listing and trading permission for 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis, effective March 6, 2026.
Summary
BSE has notified trading members that 43,04,000 new equity shares of Dr Lalchandani Labs Limited (Scrip Code: 541299) have been listed and are permitted to trade on the Exchange effective Friday, March 6, 2026. These shares were issued at par on a rights basis.
Key Points
- 43,04,000 equity shares of Rs. 10/- each issued at par on rights basis are now listed on BSE
- ISIN: INE871Z01013
- Distribution Numbers: 4333069 to 8637068
- Shares rank pari-passu with existing equity shares of the company
- Trading permitted from March 6, 2026
Regulatory Changes
No regulatory changes. This is a standard listing notification for newly allotted rights issue shares.
Compliance Requirements
Trading members are informed to enable trading in the newly listed shares from the effective date. No additional compliance action is required beyond normal trading procedures.
Important Dates
- Date of Allotment: 02 March 2026
- Trading Effective Date: 06 March 2026 (Friday)
Impact Assessment
Limited market impact. The listing adds 43,04,000 new equity shares of Dr Lalchandani Labs Limited to the tradeable float on BSE. As a rights issue, shares were offered to existing shareholders at par (Rs. 10/-). The addition is routine and company-specific with no broader market implications.
Impact Justification
Routine listing of new equity shares from a rights issue for a single company; no regulatory changes or broad market impact.